Tag Archives: drug
Reglan Lawsuit Over Use of Generics Results in Dismissal of Original Makers – AboutLawsuits.com
Reglan Lawsuit Over Use of Generics Results in Dismissal of Original Makers AboutLawsuits.com There is no known effective treatment for the problems from Reglan , and the involuntary movements often persist even after use of the drug has stopped, … Continue reading
Cops seizing ‘dial-a-doper’ vehicles – Canoe.ca
Cops seizing 'dial-a-doper' vehicles Canoe.ca “The only thing that these mobile dealers require to run their drug business is a car and a cellphone ,” Redford said. “And if we can seize the car of a drug … Alberta police use new law to seize cars from drug dealers Canada.com all 9 news articles Continue reading
Alberta police use new law to seize cars from drug dealers – Canada.com
CBC.ca Alberta police use new law to seize cars from drug dealers Canada.com “The only thing these mobile dealers require to run their drug business is a car and a cellphone . If we can seize the car of a drug dealer, that's one less … Province rakes in $11M from crooks' cash, cars and real estate Edmonton Sun all 7 news articles Continue reading
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused … – cybermed.it
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused … cybermed.it The trial was the first of about 600 US lawsuits that claim that paroxetine caused birth defects in infants born to mothers who took the drug while pregnant … Continue reading
First Paxil Birth Defects Trial A Loss for Glaxo – Newsinferno.com
eFitnessNow First Paxil Birth Defects Trial A Loss for Glaxo Newsinferno.com GlaxoSmithKline has lost the first Paxil birth defects lawsuit to go to trial, with a Pennsylvania state jury ordering the drug maker to pay $2.5 million to … Paxil Lawsuit Over Birth Defects Results in $2.5M Award in Pennsylvania AboutLawsuits.com Jury Sides with Family in Paxil Birth Defect Case PharmExec.com $2.5M verdict over birth defects blamed on Paxil The Associated Press guardian.co.uk Continue reading